176 related articles for article (PubMed ID: 24520673)
21. Polymorphisms in the vitamin D receptor gene and the androgen receptor gene and the risk of benign prostatic hyperplasia.
Bousema JT; Bussemakers MJ; van Houwelingen KP; Debruyne FM; Verbeek AL; de La Rosette JJ; Kiemeney LA
Eur Urol; 2000 Feb; 37(2):234-8. PubMed ID: 10705205
[TBL] [Abstract][Full Text] [Related]
22. Androgen receptor CAG repeat length is not associated with the risk of incident symptomatic benign prostatic hyperplasia: results from the Prostate Cancer Prevention Trial.
Kristal AR; Price DK; Till C; Schenk JM; Neuhouser ML; Ockers S; Lin DW; Thompson IM; Figg WD
Prostate; 2010 May; 70(6):584-90. PubMed ID: 19938041
[TBL] [Abstract][Full Text] [Related]
23. Androgen receptor CAG polymorphism and the risk of benign prostatic hyperplasia in a Brazilian population.
Biolchi V; Silva Neto B; Koff W; Brum IS
Int Braz J Urol; 2012; 38(3):373-9. PubMed ID: 22765868
[TBL] [Abstract][Full Text] [Related]
24. Polymorphic forms of prostate specific antigen and their interaction with androgen receptor trinucleotide repeats in prostate cancer.
Binnie MC; Alexander FE; Heald C; Habib FK
Prostate; 2005 Jun; 63(4):309-15. PubMed ID: 15599941
[TBL] [Abstract][Full Text] [Related]
25. The place of androgen receptor gene mutation analysis in the molecular diagnosis of prostate cancer and genotype-phenotype relationship.
Kizilay F; Kalemci MS; Şimşir A; Turna B; Nazli O; Berdeli A
Turk J Med Sci; 2014; 44(2):261-6. PubMed ID: 25536734
[TBL] [Abstract][Full Text] [Related]
26. Androgen receptor gene polymorphisms and risk of prostate cancer: a meta-analysis.
Weng H; Li S; Huang JY; He ZQ; Meng XY; Cao Y; Fang C; Zeng XT
Sci Rep; 2017 Jan; 7():40554. PubMed ID: 28091563
[TBL] [Abstract][Full Text] [Related]
27. Effect of the androgen receptor CAG repeat polymorphism on transcriptional activity: specificity in prostate and non-prostate cell lines.
Beilin J; Ball EM; Favaloro JM; Zajac JD
J Mol Endocrinol; 2000 Aug; 25(1):85-96. PubMed ID: 10915221
[TBL] [Abstract][Full Text] [Related]
28. The androgen receptor CAG repeat length polymorphism associates with prostate volume in Finnish men with benign prostatic hyperplasia.
Renko O; Savolainen ER; Loikkanen I; Paavonen TK; Vaarala MH
DNA Cell Biol; 2008 Feb; 27(2):109-13. PubMed ID: 17979523
[TBL] [Abstract][Full Text] [Related]
29. How strong is the association between CAG and GGN repeat length polymorphisms in the androgen receptor gene and prostate cancer risk?
Zeegers MP; Kiemeney LA; Nieder AM; Ostrer H
Cancer Epidemiol Biomarkers Prev; 2004 Nov; 13(11 Pt 1):1765-71. PubMed ID: 15533905
[TBL] [Abstract][Full Text] [Related]
30. The CAG repeat polymorphism of androgen receptor gene and prostate cancer: a meta-analysis.
Gu M; Dong X; Zhang X; Niu W
Mol Biol Rep; 2012 Mar; 39(3):2615-24. PubMed ID: 21667251
[TBL] [Abstract][Full Text] [Related]
31. Shorter GGN Repeats in Androgen Receptor Gene Would Not Increase the Risk of Prostate Cancer.
Li J; Xiao F; Zhang Y; Lan A; Song Q; Zhang R; Gu K; Chen P; Li Z; Zhang X; Yang X
Technol Cancer Res Treat; 2017 Apr; 16(2):159-166. PubMed ID: 28279145
[TBL] [Abstract][Full Text] [Related]
32. Are GSTM1, GSTT1 and CAG repeat length of androgen receptor gene polymorphisms associated with risk of prostate cancer in Iranian patients?
Ashtiani ZO; Hasheminasab SM; Ayati M; Goulian BS; Modarressi MH
Pathol Oncol Res; 2011 Jun; 17(2):269-75. PubMed ID: 21089003
[TBL] [Abstract][Full Text] [Related]
33. Androgen receptor CAG repeat polymorphism in prostate cancer from a Brazilian population.
Santos ML; Sarkis AS; Nishimoto IN; Nagai MA
Cancer Detect Prev; 2003; 27(5):321-6. PubMed ID: 14585317
[TBL] [Abstract][Full Text] [Related]
34. CAG repeat length in the androgen receptor gene is related to age at diagnosis of prostate cancer and response to endocrine therapy, but not to prostate cancer risk.
Bratt O; Borg A; Kristoffersson U; Lundgren R; Zhang QX; Olsson H
Br J Cancer; 1999 Oct; 81(4):672-6. PubMed ID: 10574254
[TBL] [Abstract][Full Text] [Related]
35. CCR2 and CCR5 genes polymorphisms in benign prostatic hyperplasia and prostate cancer.
Zambra FM; Biolchi V; Brum IS; Chies JA
Hum Immunol; 2013 Aug; 74(8):1003-8. PubMed ID: 23632061
[TBL] [Abstract][Full Text] [Related]
36. Impact of constitutional genetic variation in androgen/oestrogen-regulating genes on age-related changes in human prostate.
Azzouzi AR; Cochand-Priollet B; Mangin P; Fournier G; Berthon P; Latil A; Cussenot O
Eur J Endocrinol; 2002 Oct; 147(4):479-84. PubMed ID: 12370109
[TBL] [Abstract][Full Text] [Related]
37. Polymorphic CAG and GGN repeat lengths in the androgen receptor gene and prostate cancer risk: a population-based case-control study in China.
Hsing AW; Gao YT; Wu G; Wang X; Deng J; Chen YL; Sesterhenn IA; Mostofi FK; Benichou J; Chang C
Cancer Res; 2000 Sep; 60(18):5111-6. PubMed ID: 11016637
[TBL] [Abstract][Full Text] [Related]
38. Polymorphic CAG and GGC repeat lengths in the androgen receptor gene and prostate cancer risk: analysis of a Brazilian population.
Silva Neto B; Koff WJ; Biolchi V; Brenner C; Biolo KD; Spritzer PM; Brum IS
Cancer Invest; 2008 Feb; 26(1):74-80. PubMed ID: 18181049
[TBL] [Abstract][Full Text] [Related]
39. [CAG microsatellite polymorphisms of androgen receptor gene and the stage and grade of prostate cancer].
Li C; Dong J; Guan W
Zhonghua Zhong Liu Za Zhi; 2001 May; 23(3):217-9. PubMed ID: 11783090
[TBL] [Abstract][Full Text] [Related]
40. Androgen receptor polymorphisms and the incidence of prostate cancer.
Chen C; Lamharzi N; Weiss NS; Etzioni R; Dightman DA; Barnett M; DiTommaso D; Goodman G
Cancer Epidemiol Biomarkers Prev; 2002 Oct; 11(10 Pt 1):1033-40. PubMed ID: 12376504
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
